AU5480173A - Piperidine derivatives - Google Patents

Piperidine derivatives

Info

Publication number
AU5480173A
AU5480173A AU54801/73A AU5480173A AU5480173A AU 5480173 A AU5480173 A AU 5480173A AU 54801/73 A AU54801/73 A AU 54801/73A AU 5480173 A AU5480173 A AU 5480173A AU 5480173 A AU5480173 A AU 5480173A
Authority
AU
Australia
Prior art keywords
formula
compound
stated
benzyl
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU54801/73A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz Patent Ltd
Sandoz AG
Original Assignee
Sandoz Patent Ltd
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Patent Ltd, Sandoz AG filed Critical Sandoz Patent Ltd
Publication of AU5480173A publication Critical patent/AU5480173A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
AU54801/73A 1967-04-19 1973-04-19 Piperidine derivatives Expired AU5480173A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH558967A CH497458A (de) 1967-04-19 1967-04-19 Verfahren zur Herstellung neuer Phenothiazin-Derivate
CH1705667 1967-12-05

Publications (1)

Publication Number Publication Date
AU5480173A true AU5480173A (en) 1973-07-12

Family

ID=25698043

Family Applications (2)

Application Number Title Priority Date Filing Date
AU54801/73A Expired AU5480173A (en) 1967-04-19 1973-04-19 Piperidine derivatives
AU54802/73A Expired AU5480273A (en) 1967-04-19 1973-04-19 Phenothiazine derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU54802/73A Expired AU5480273A (en) 1967-04-19 1973-04-19 Phenothiazine derivatives

Country Status (17)

Country Link
US (1) US3531480A (enExample)
AT (2) AT293372B (enExample)
AU (2) AU5480173A (enExample)
BE (1) BE713802A (enExample)
BG (1) BG17326A3 (enExample)
CH (1) CH497458A (enExample)
DE (1) DE1770218A1 (enExample)
ES (1) ES352822A1 (enExample)
FR (1) FR1583822A (enExample)
GB (2) GB1223315A (enExample)
IE (2) IE32170B1 (enExample)
IL (2) IL36239A (enExample)
NL (1) NL6804983A (enExample)
NO (1) NO124997B (enExample)
OA (1) OA03386A (enExample)
RO (1) RO54395A (enExample)
SE (2) SE361884B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857943A (en) * 1969-03-27 1974-12-31 May & Baker Ltd New phenothiazine derivatives in the treatment of spasticity of muscles
CH511885A (de) * 1969-07-08 1971-08-31 Sandoz Ag Verfahren zur Herstellung neuer Furanonderivate
US6310059B1 (en) * 1998-06-30 2001-10-30 Neuromed Technologies, Inc. Fused ring calcium channel blockers
US20040259866A1 (en) * 1998-06-30 2004-12-23 Snutch Terrance P. Calcium channel blockers comprising two benzhydril moieties
WO2007133481A2 (en) * 2006-05-11 2007-11-22 Neuromed Pharmaceuticals Ltd. Method for increasing the bioavailability of benzhydryl piperazine containing compounds
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
WO2012122279A1 (en) 2011-03-08 2012-09-13 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1212031A (fr) * 1957-10-21 1960-03-21 Rhone Poulenc Sa Dérivés de la phénothiazine substitués à l'azote par une chaîne basique comportant un hétérocycle et leur préparation

Also Published As

Publication number Publication date
GB1223314A (en) 1971-02-24
NO124997B (enExample) 1972-07-03
SE361884B (enExample) 1973-11-19
IL29842A (en) 1971-05-26
IE32170L (en) 1968-10-19
AT292726B (de) 1971-09-10
US3531480A (en) 1970-09-29
DE1770218A1 (de) 1971-10-14
IE32169L (en) 1968-10-19
GB1223315A (en) 1971-02-24
IE32170B1 (en) 1973-05-02
BE713802A (enExample) 1968-10-17
CH497458A (de) 1970-10-15
AT293372B (de) 1971-10-11
RO54395A (enExample) 1973-02-17
ES352822A1 (es) 1969-11-16
IL36239A (en) 1971-06-23
OA03386A (fr) 1970-12-15
NL6804983A (enExample) 1968-10-21
BG17326A3 (enExample) 1973-07-25
IE32169B1 (en) 1973-05-02
IL29842A0 (en) 1968-06-20
SE356520B (enExample) 1973-05-28
AU5480273A (en) 1973-07-12
FR1583822A (enExample) 1969-12-05

Similar Documents

Publication Publication Date Title
YU31236B (en) Tranzistorski sirokopojasni pojacivac sa regulatorom pojacanja
CY766A (en) 4-phenyl-quinazolinone derivatives
IE32353L (en) Phenoxypropanolamine derivatives
AU5480273A (en) Phenothiazine derivatives
IE32152L (en) Piperazine derivatives
IE32312L (en) 5-benzylpyrimidine derivatives
IE31847L (en) Piperidine derivatives
IL29920A (en) Oxazinoisoquinoline derivatives
CA772620A (en) Piperidine derivatives
CA771674A (en) Piperidine derivatives
IE31083L (en) Naphthylcyclopentanone derivatives
IE31391L (en) Phenylaminoethanol derivatives
IE31133L (en) Pseudo-indole derivatives
IL27676A (en) Gonene derivatives
IE31358L (en) Indenopyridine derivatives
IE32895B1 (en) Aminoacetylaminobenzophenone derivatives
IE30670L (en) 6-keto-steroid derivatives
IE31199L (en) Sulphonyl-urea derivatives
IE30727L (en) 5-benzylpyrimidine derivatives
IE31359L (en) Indenopyridine derivatives
IE32317L (en) Azimidobenzamide derivatives
IE32574L (en) Phenyl - heterocyclic - alkanoyl derivatives
IE31092L (en) Diarylcyclopropane derivatives
IE30851L (en) Phenyl-aminopropane derivatives
IE32477B1 (en) 4-phenyl-quinazolidone derivatives